Literature DB >> 27332558

Functional Dyspepsia and Gastroparesis.

Michael Camilleri1.   

Abstract

BACKGROUND: Upper gastrointestinal disorders typically present with common symptoms. The most relevant non-mucosal diseases are gastroparesis, functional dyspepsia and rumination syndrome. The literature pertaining to these 3 conditions was reviewed. KEY MESSAGES: Gastroparesis is characterized by delayed gastric emptying in the absence of mechanical obstruction of the stomach. The cardinal symptoms include postprandial fullness (early satiety), nausea, vomiting and bloating. The most frequently encountered causes of these symptoms are mechanical obstruction (pyloric stenosis), iatrogenic disease, gastroparesis, functional dyspepsia, cyclical vomiting and rumination syndrome. The most common causes of gastroparesis are neuropathic disorders such as diabetes, idiopathic, post-vagotomy and scleroderma among myopathic disorders. Principles of management of gastroparesis include exclusion of mechanical obstruction with imaging and iatrogenic causes with careful medication and past surgical history. Prokinetics and anti-emetics are the mainstays of treatment. Functional dyspepsia is characterized by the same symptoms as gastroparesis; in addition to delayed gastric emptying, pathophysiological abnormalities include accelerated gastric emptying, impaired gastric accommodation and gastric or duodenal hypersensitivity to distension and nutrients. Novel treatments include tricyclic antidepressants in patients with normal gastric emptying, acotiamide (acetyl cholinesterase inhibitor) and 5-HT1A receptor agonists such as buspirone. Rumination syndrome is characterized by repetitive regurgitation of gastric contents occurring within minutes after a meal. Episodes often persist for 1-2 h after the meal, and the regurgitant consists of partially digested food that is recognizable in its taste. Regurgitation is typically effortless or preceded by a sensation of belching. This has been summarized as a 'meal in, meal out, day in, day out' behavior for weeks or months, differentiating rumination from gastroparesis. Patients often have a background of psychological disorder or a prior eating disorder. Treatment is based on behavioral modification.
CONCLUSION: Precise identification of the cause and pathophysiology of upper gastrointestinal symptoms is essential for optimal management.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27332558     DOI: 10.1159/000445226

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  16 in total

1.  Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities.

Authors:  Thomas L Abell; Archana Kedar; Abigail Stocker; Karen Beatty; Lindsay McElmurray; Michael Hughes; Hani Rashed; William Kennedy; Gwen Wendelschafer-Crabb; Xiu Yang; Mostafa Fraig; Leila Gobejishvili; Endashaw Omer; Ed Miller; Michael Griswold; Christina Pinkston
Journal:  Dig Dis Sci       Date:  2020-04-23       Impact factor: 3.199

2.  Fluoroscopy-guided gastric peroral endoscopic pyloromyotomy (G-POEM): a more reliable and efficient method for treatment of refractory gastroparesis.

Authors:  H B Xue; H Z Fan; X M Meng; S Cristofaro; P Mekaroonkamol; S Dacha; L Y Li; X L Fu; S H Zhan; Q Cai
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

Review 3.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

Review 4.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

5.  Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial.

Authors:  Justin Brandler; Laurence J Miller; Xiao Jing Wang; Duane Burton; Irene Busciglio; Kayla Arndt; William S Harmsen; Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-10       Impact factor: 4.052

6.  A Critical Review of the Current Clinical Landscape of Gastroparesis.

Authors:  Chimi L Fosso; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

7.  Clinical Predictors of Rapid Gastric Emptying in Patients Presenting with Dyspeptic Symptoms.

Authors:  Juan Gomez Cifuentes; Mark Radetic; Rocio Lopez; Scott Gabbard
Journal:  Dig Dis Sci       Date:  2019-04-13       Impact factor: 3.199

8.  From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2017-06-02       Impact factor: 3.199

9.  Gastroparesis and lipid metabolism-associated dysbiosis in Wistar-Kyoto rats.

Authors:  J E Dalziel; Karl Fraser; Wayne Young; Catherine M McKenzie; Shalome A Bassett; Nicole C Roy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-13       Impact factor: 4.052

10.  Patients with symptoms of delayed gastric emptying have a high prevalence of oesophageal dysmotility, irrespective of scintigraphic evidence of gastroparesis.

Authors:  George Triadafilopoulos; Linda Nguyen; John O Clarke
Journal:  BMJ Open Gastroenterol       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.